Cholera bacteria aren't just battling antibiotics and public health measures—they are also constantly under attack from ...

Bharat Biotech's oral Cholera Vaccine, Hillchol, has successfully completed phase III clinical trials, demonstrating ...

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

In this study, participants were divided into three age groups: adults over 18 years, children aged 5 to under 18 years, and ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Heal the Bay’s annual beach report card just came out, and the water at the Santa Monica Pier is once again some of the ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...